| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bone marrow transplantation for myelodysplasia in adults and children: when and who?
|
R. Appelbaum, Frederick
|
|
1998
|
22 |
S1 |
p. S35-S39
5 p.
|
article
|
| 2 |
Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients
|
Miller, K
|
|
1998
|
22 |
S1 |
p. S13-S16
4 p.
|
article
|
| 3 |
Hematopoietic stimulation by amifostine and sodium phenylbutyrate: what is the potential in MDS?
|
List, Alan F
|
|
1998
|
22 |
S1 |
p. S7-S11
5 p.
|
article
|
| 4 |
Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities
|
Hiddemann, W
|
|
1998
|
22 |
S1 |
p. S23-S26
4 p.
|
article
|
| 5 |
Meeting highlights: therapeutic strategies and supportive care in myelodysplastic syndromes: yesterday, today and tomorrow
|
Bennett, John M
|
|
1998
|
22 |
S1 |
p. S1-S2
2 p.
|
article
|
| 6 |
Quality of life and psychosocial adjustment in patients with myelodysplastic syndromes
|
Thomas, Mary Laudon
|
|
1998
|
22 |
S1 |
p. S41-S47
7 p.
|
article
|
| 7 |
Reducing the toxicity of anticancer therapy: new strategies
|
Griggs, Jennifer J
|
|
1998
|
22 |
S1 |
p. S27-S33
7 p.
|
article
|
| 8 |
Risk factors and their relationship to prognosis in myelodysplastic syndromes
|
Greenberg, Peter L
|
|
1998
|
22 |
S1 |
p. S3-S6
4 p.
|
article
|
| 9 |
Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes
|
Cheson, Bruce D
|
|
1998
|
22 |
S1 |
p. S17-S21
5 p.
|
article
|
Journal description